Adipose-Derived Therapeutic Products for the Management of Refractory Crohn's Fistula
Gastroenterology
.
2019 Dec;157(6):1690-1691.
doi: 10.1053/j.gastro.2019.05.078.
Epub 2019 Sep 19.
Authors
Fanny Grimaud
1
,
Mélanie Serrero
2
,
Jérémy Magalon
3
Affiliations
1
Cell Therapy Department, INSERM CBT 1409, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
2
Gastroenterology Department, Assistance Publique Hôpitaux de Marseille, CHU of Marseille, Marseille, France.
3
Cell Therapy Department, INSERM CBT 1409, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Faculté de Pharmacie de Marseille, INSERM, INRA, C2VN, Faculté de Pharmacie de Marseille, Aix Marseille University, Marseille, France.
PMID:
31542411
DOI:
10.1053/j.gastro.2019.05.078
No abstract available
Publication types
Letter
Comment
MeSH terms
Adipose Tissue
Adiposity
Crohn Disease*
Fistula*
Humans